M. Jagasia

发表

Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology.

J. Radich, H. Kantarjian, K. Gregory, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

Registries and artificial intelligence: investing in the future of hematopoietic cell transplantation

Ibrahim N. Muhsen, S. Hashmi, M. Jagasia, 2018, Bone Marrow Transplantation.

Pituitary Apoplexy During Hematopoietic Cell Transplantation.

B. Mobley, M. Jagasia, M. Byrne, 2020, Clinical lymphoma, myeloma & leukemia.

Quantitative assessment of myeloid nuclear differentiation antigen distinguishes myelodysplastic syndrome from normal bone marrow.

W. Dupont, D. Head, C. Mosse, 2009, American journal of clinical pathology.

Crowdsourcing to delineate skin affected by chronic graft‐vs‐host disease

Joseph R. Coco, B. Dawant, E. Tkaczyk, 2019, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHD.

Heidi Chen, H. Greinix, C. Scheid, 2019, Blood advances.

Pretransplantation C-Peptide level predicts early posttransplantation diabetes mellitus and has an impact on survival after allogeneic stem cell transplantation.

Heidi Chen, A. Kassim, B. Savani, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I Trial.

R. Collins, P. Hari, M. Maris, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: Prognostic features and outcomes

A. Kassim, S. Brandt, D. Morgan, 2007, Leukemia & lymphoma.

Dysregulated human myeloid nuclear differentiation antigen expression in myelodysplastic syndromes: evidence for a role in apoptosis.

D. Head, J. Jacobberger, F. Boulos, 2006, Cancer research.

Early viral reactivation despite excellent immune reconstitution following haploidentical Bone marrow transplant with post‐transplant cytoxan for sickle cell disease

Heidi Chen, A. Kassim, J. de la Fuente, 2019, Transplant infectious disease : an official journal of the Transplantation Society.

Relapse post hematopoietic SCT remains the Achilles heel for the field

H. Frangoul, M. Jagasia, 2014, Bone Marrow Transplantation.

Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome.

J. Sierra, J. Dipersio, B. George, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ibrutinib for chronic graft-versus-host disease after failure of prior therapy.

A. Logan, D. Miklos, M. Flowers, 2017, Blood.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease

H. Greinix, Stephanie J. Lee, M. Flowers, 2015 .

Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life.

Tueng T. Shen, Tueng Shen, J. Pidala, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium.

B. Kurland, J. Pidala, Stephanie J. Lee, 2012, Blood.

Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria

A. Kassim, J. Greer, B. Savani, 2012, Bone Marrow Transplantation.

Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.

B. Storer, J. Pidala, Stephanie J. Lee, 2011, Blood.

A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation

T. Braun, P. Hari, P. Westervelt, 2017, Bone Marrow Transplantation.

Diabetes mellitus after hematopoietic stem cell transplantation.

M. Jagasia, S. Jagasia, M. Griffith, 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy

R. Larson, M. Baccarani, D. Marin, 2010, Leukemia.

Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes.

M. Aljurf, R. Gale, K. Ballen, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Individual cell motion in healthy human skin microvasculature by reflectance confocal video microscopy

E. Tkaczyk, M. Jagasia, J. Patrinely, 2020, Microcirculation.

NCCN clinical practice guidelines in oncology: multiple myeloma.

J. Vose, K. Anderson, S. Singhal, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.

K. Washington, T. Morton, D. Kleiner, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Positron emission tomography/computed tomography of a rare xanthogranulomatous process: Erdheim-Chester disease.

Mahlon D. Johnson, W. Martin, D. Delbeke, 2004, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial

J. Szer, E. Waller, G. Long, 2012, Bone Marrow Transplantation.

Weekly irinotecan and concurrent radiation therapy for stage III unresectable NSCLC.

H. Choy, A. Chakravarthy, D. Johnson, 2000, Oncology.

Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies

J. Bourhis, N. Kröger, P. Chevallier, 2021, Frontiers in Immunology.

Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell Malignancies.

A. Kassim, J. Greer, B. Savani, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Expression of CD30 in patients with acute graft-versus-host disease.

J. Ritz, R. Soiffer, Heidi Chen, 2012, Blood.

Rituximab-containing reduced-intensity conditioning improves progression-free survival following allogeneic transplantation in B cell non-Hodgkin lymphoma

Sonali M. Smith, S. Devine, S. Jaglowski, 2017, Journal of Hematology & Oncology.

Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma.

O. Oluwole, J. Greer, B. Savani, 2014, Experimental hematology.

Consolidative therapy with stem cell transplantation improves survival of patients with mantle cell lymphoma after any induction regimen.

A. Kassim, S. Brandt, O. Oluwole, 2012, Experimental hematology.

Transfer RNA detection by small RNA deep sequencing and disease association with myelodysplastic syndromes

Annette S. Kim, K. Vickers, Yan Guo, 2015, BMC Genomics.

Chronic myelogenous leukemia, version 1.2014: Featured updates to the NCCN guidelines

J. Radich, K. Gregory, Hema M Sundar, 2013 .

Chronic Myelogenous Leukemia, Version 1.2014.

J. Radich, K. Gregory, Hema M Sundar, 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma

S. Phillips, A. Kassim, R. Cornell, 2018, Bone Marrow Transplantation.

Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agents

S. Goldhaber, J. Moslehi, G. Piazza, 2020, British journal of haematology.

National Institutes of Health Blood and Marrow Transplant LateEffects Initiative: The Healthcare Delivery Working Group Report

Kimberly, Susan, C. Bredeson, 2017 .

National Institutes of Health Blood and Marrow Transplant Late Effects Initiative: The Healthcare Delivery Working Group Report.

M. Flowers, C. Bredeson, S. Hashmi, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of BCR/ABL1 mRNA levels by quantitative real-time PCR in peripheral blood and bone marrow specimens of patients with chronic myelogenous leukemia

C. Vnencak-Jones, M. Jagasia, Jessica Thomas, 2017, Leukemia & lymphoma.

Histology Impacts the Outcome of Peripheral T-Cell Lymphomas after High Dose Chemotherapy and Stem Cell Transplant

Y. Shyr, J. Zic, D. Morgan, 2004, Leukemia & lymphoma.

New‐onset posttransplant diabetes mellitus after haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide

Heidi Chen, A. Kassim, M. Jagasia, 2020, EJHaem.

PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: high response rate but frequent GVHD.

P. Hari, S. Mineishi, P. Armand, 2017, Blood.

PDGFRB-rearranged T-lymphoblastic leukemia/lymphoma occurring with myeloid neoplasms: the missing link supporting a stem cell origin

Annette S. Kim, J. Giltnane, D. Head, 2014, Haematologica.

Sexual health in hematopoietic stem cell transplant recipients

M. Mohty, B. Shaw, P. Stratton, 2015, Cancer.

Video-assisted talc pleurodesis in the management of pleural effusion secondary to continuous ambulatory peritoneal dialysis: a report of three cases.

M. Jagasia, F. Cole, P. Deaton, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Surgical Considerations for Tumor Tissue Procurement to Obtain Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy

Michael E. Egger, John E. Mullinax, B. Monk, 2022, Cancer Journal.

Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.

R. Vij, D. Lad, M. Perales, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Time to explore preventive and novel therapies for bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation.

B. Savani, M. Jagasia, S. Srivastava, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival.

J. Crowe, M. Rock, S. Yoder, 2012, Experimental hematology.

Regulatory T cell expression of CLA or α4β7 and skin or gut acute GVHD outcomes

J. Crowe, M. Rock, S. Yoder, 2011, Bone Marrow Transplantation.

ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease

J. Weiss, Stephanie J. Lee, O. Schueller, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Chronic Graft-vs.-Host Disease Failure-Free Survival (cGVHD-FFS) index.

B. Storer, J. Pidala, Stephanie J. Lee, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Ibrutinib for Chronic Graft-Versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 Study.

A. Logan, D. Miklos, M. Flowers, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Organ Changes Associated with Provider-Assessed Responses in Patients with Chronic Graft-versus-Host Disease.

B. Storer, J. Pidala, Stephanie J. Lee, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Design and Patient Characteristics of the Chronic Graft-versus-Host Disease Response Measures Validation Study.

J. Pidala, Stephanie J. Lee, M. Flowers, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease.

B. Storer, J. Pidala, Stephanie J. Lee, 2017, Blood.

FAM treatment for new onset bronchiolitis obliterans syndrome after hematopoietic cell transplantation

J. Pidala, Stephanie J. Lee, M. Flowers, 2016 .

Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.

B. Storer, J. Pidala, Stephanie J. Lee, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pulmonary symptoms measured by the NIH Lung score predict overall survival, non-relapse mortality and patient-reported outcomes in chronic GVHD

W. Wood, B. Kurland, J. Pidala, 2014 .

Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease.

W. Wood, B. Kurland, J. Pidala, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease.

B. Storer, K. van Besien, Stephanie J. Lee, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison between short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease

B. Storer, Stephanie J. Lee, D. Couriel, 2011 .

Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma.

J. Moslehi, B. Ky, A. Kassim, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Individual physician practice variation in hematopoietic cell transplantation.

R. Soiffer, Stephanie J. Lee, S. Davies, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report.

G. Cuvelier, J. Pidala, H. Greinix, 2021, Transplantation and cellular therapy.

A Prospective Trial of Extracorporeal Photopheresis for Chronic Graft-versus-Host Disease Reveals Significant Disease Response and No Association with Frequency of Regulatory T Cells.

D. K. Jung, Heidi Chen, Yi-Bin Chen, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cardiovascular Complications of Novel Multiple Myeloma Treatments

J. Moslehi, G. Piazza, D. Lenihan, 2016, Circulation.

Chronic myelogenous leukemia, version 1.2015.

J. Radich, K. Gregory, Hema M Sundar, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research.

Alan M. Miller, M. Norkin, P. Hari, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Rapidly fatal pneumonitis from immunotherapy and concurrent SARS-CoV-2 infection in a patient with newly diagnosed lung cancer

P. Gonzalez-Ericsson, Douglas B. Johnson, J. Balko, 2020, medRxiv.

Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT

A. Kassim, B. Savani, M. Jagasia, 2011, Bone Marrow Transplantation.

Monitoring residual myeloma: high-resolution serum/urine electrophoresis or marrow biopsy with immunohistochemical analysis?

Armanda D. Tatsas, Heidi Chen, M. Jagasia, 2010, American journal of clinical pathology.

Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label, phase 2 trial.

M. Arbushites, M. Perales, H. Khoury, 2020, Blood.

Innovative Analyses Support a Role for DNA Damage and an Aberrant Cell Cycle in Myelodysplastic Syndrome Pathogenesis

W. Dupont, D. Head, J. Jacobberger, 2011, Bone marrow research.

Cytotoxic T-lymphocyte antigen-4 single nucleotide polymorphisms are not associated with outcomes after unrelated donor transplantation: a center for international blood and marrow transplant research analysis.

Stephanie J. Lee, S. Spellman, Tao Wang, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chronic Myeloid Leukemia , Version 1 . 2019 Clinical Practice Guidelines in Oncology

J. Radich, H. Kantarjian, K. Gregory, 2018 .

New allergies after cord blood transplantation.

A. Kassim, H. Frangoul, J. Greer, 2013, Cytotherapy.

Pegfilgrastim after high-dose chemotherapy and autologous peripheral blood stem cell transplant: phase II study

S. Mineishi, A. Kassim, D. Morgan, 2005, Bone Marrow Transplantation.

Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.

J. Fay, B. Storer, J. Wingard, 2009, Blood.

Age and Cytogenetics as Predictors of Event Free Survival in Patients with Acute Non-Lymphocytic Leukemia Receiving High Dose Cytosine Arabinoside and Daunorubicin as Consolidation Chemotherapy

S. Brandt, D. Morgan, J. Greer, 2001, Leukemia & lymphoma.

The use of venetoclax‐based salvage therapy for post‐hematopoietic cell transplantation relapse of acute myeloid leukemia

R. Jayani, A. Kassim, B. Savani, 2020, American journal of hematology.

Allogeneic hematopoietic stem cell transplant (HSCT) in adults with acute myeloid leukemia (AML) – a single program experience

R. Obenchain, A. Kassim, S. Brandt, 2006 .

Superior long-term outcome of patients with early transformation of non-Hodgkin lymphoma undergoing stem cell transplantation.

O. Oluwole, J. Greer, B. Savani, 2012, Clinical lymphoma, myeloma & leukemia.

Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis

B. Sandmaier, M. Aljurf, R. Gale, 2016, Cancer.

Biomarkers in chronic graft-versus-host disease: quo vadis?

E. Weissinger, E. Holler, J. Hansen, 2018, Bone Marrow Transplantation.

International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium.

D. Porter, F. Locatelli, E. Holler, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HISTOPATHOLOGIC DIAGNOSIS OF CHRONIC GRAFT VERSUS HOST DISEASE: NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: II. The 2014 Pathology Working Group Report

T. Morton, D. Kleiner, J. Greenson, 2015 .

Referral to transplant center for hematopoietic cell transplantation.

N. Majhail, M. Jagasia, 2014, Hematology/oncology clinics of North America.

Gastric Graft-Versus-Host Disease Revisited: Does Proton Pump Inhibitor Therapy Affect Endoscopic Gastric Biopsy Interpretation?

K. Washington, P. Wirth, J. Goldenring, 2006, The American journal of surgical pathology.

Management of relapse after allo-SCT for AML and the role of second transplantation

S. Mielke, K. Rezvani, B. Savani, 2009, Bone Marrow Transplantation.

Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different in vivo Depletion Strategies in Predicting Outcomes of Allogeneic Transplant: An International 2 Center Experience

G. Mufti, D. Mclornan, A. Kassim, 2019, Front. Oncol..

Evaluating new treatment options for MDS.

A. Yang, G. Garcia-Manero, M. Jagasia, 2007, Clinical advances in hematology & oncology : H&O.

Increased BCR responsiveness in B cells from patients with chronic GVHD.

J. Serody, A. Deal, K. Richards, 2014, Blood.

Risk factors for acute GVHD and survival after hematopoietic cell transplantation.

M. Horowitz, R. Gale, Stephanie J. Lee, 2012, Blood.

NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017.

J. Radich, H. Kantarjian, K. Gregory, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

Chronic Myeloid Leukemia , Version 1 . 2017 Featured Updates to the NCCN Guidelines

J. Radich, H. Kantarjian, K. Gregory, 2022 .

103: Poor outcome of autologous-bone marrow transplant (auto-BMT) following failed peripheral blood stem cell (PBSC) mobilization

Heidi Chen, A. Kassim, D. Morgan, 2007 .

An early-biomarker algorithm predicts lethal graft-versus-host disease and survival.

N. Kröger, F. Locatelli, E. Holler, 2017, JCI insight.

Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide

J. Wagner, L. Freedman, J. Kurtzberg, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease.

M. Arbushites, J. Dipersio, M. Perales, 2020, Blood advances.

Pathophysiology and Management of Graft-Versus-Host Disease

M. Jagasia, Ragisha Gopalakrishnan, 2019, Hematopoietic Cell Transplantation for Malignant Conditions.

The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.

A. Barrett, M. Horowitz, J. Wingard, 2009, Blood.

Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis.

M. Robin, N. Russell, H. Greinix, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors.

W. Wood, B. Storer, J. Pidala, 2016, Blood.

303: Incidence and outcome of chronic graft-versus-host disease (cGVHD) after allogeneic stem cell transplant (SCT) using National Institute of Health (NIH) consensus criteria

Heidi Chen, A. Kassim, H. Frangoul, 2007 .

ORIGINAL ARTICLE Expression of a4b7 integrin on memory CD8 þ T cells at the presentation of acute intestinal GVHD

J. Ritz, K. Ballen, R. Soiffer, 2013 .

Balancing Value with Affordability: Cell Immunotherapy for Cancer Treatment in the U.S.

Joshua T. Cohen, P. Neumann, S. Dusetzina, 2020, The oncologist.

Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study

A. Logan, D. Howard, J. Liesveld, 2021, Blood.

Effect of Antihuman T Lymphocyte Globulin on Immune Recovery after Myeloablative Allogeneic Stem Cell Transplantation with Matched Unrelated Donors: Analysis of Immune Reconstitution in a Double-Blind Randomized Controlled Trial.

J. Ritz, P. Westervelt, J. Dipersio, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Organ Changes Associated with Provider-Assessed Responses in Patients with Chronic GVHD

B. Storer, J. Pidala, Stephanie J. Lee, 2019 .

Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic cell transplantation for hematologic malignancies.

D. Crawford, K. Brown-Gentry, Heidi Chen, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Ruxolitinib for the treatment of patients with steroid-refractory GVHD: an introduction to the REACH trials.

M. Arbushites, M. Jagasia, R. Zeiser, 2018, Immunotherapy.

Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survival.

Alan M. Miller, R. Vij, M. Aljurf, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

789 Lifileucel TIL cell monotherapy in patients with advanced melanoma after progression on immune checkpoint inhibitors (ICI) and targeted therapy: pooled analysis of consecutive cohorts (C-144–01 study)

J. Kirkwood, P. Hari, H. Kluger, 2022, Regular and Young Investigator Award Abstracts.

Failure-free survival in a prospective cohort of patients with chronic graft-versus-host disease

J. Pidala, Stephanie J. Lee, M. Flowers, 2015, Haematologica.

transplantation Risk factors for acute GVHD and survival after hematopoietic cell

M. Horowitz, R. Gale, Stephanie J. Lee, 2012 .

Expression of α4β7 integrin on memory CD8+ T cells at the presentation of acute intestinal GVHD

J. Ritz, K. Ballen, R. Soiffer, 2013, Bone Marrow Transplantation.

Comorbidity Burden in Patients with Chronic Graft Versus Host Disease

W. Wood, B. Storer, J. Pidala, 2014 .

Does peritransplantation use of rituximab reduce the risk of EBV reactivation and PTLPD?

P. Pohlmann, A. Kassim, J. Greer, 2009, Blood.

Defining Incidence and Risk Factors for Catheter-Associated Bloodstream Infections in an Outpatient Adult Hematopoietic Cell Transplantation Program.

Heidi Chen, A. Kassim, B. Savani, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts.

J. Wingard, K. Ballen, Juan Wu, 2011, Blood.

transplantation superior to HLA-identical siblings for hematopoietic stem cell The graft-versus-leukemia effect using matched unrelated donors is not

J. Wingard, P. McCarthy, S. Spellman, 2011 .

Analysis of gastrointestinal and hepatic chronic grant-versus-host disease manifestations on major outcomes

B. Kurland, J. Pidala, Stephanie J. Lee, 2013 .

Belumosudil for Chronic Graft-Versus-Host Disease (cGVHD) after 2 or More Prior Lines of Therapy: The Rockstar Study (KD025-213)

Stephanie J. Lee, O. Schueller, B. Blazar, 2020, Transplantation and Cellular Therapy.

Refractory acute graft-versus-host disease: a new working definition beyond corticosteroid refractoriness.

R. Jenq, M. Mohty, E. Holler, 2020, Blood.

Minimal residual disease in myeloma: are we there yet?

Annette S. Kim, A. Kassim, C. Mosse, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Conditioning regimens for allogeneic hematopoietic stem cell transplants in acute myeloid leukemia

A. Nagler, M. Mohty, A. Bacigalupo, 2017, Bone Marrow Transplantation.

Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated Influenza Vaccine in Adult Hematopoietic Stem Cell Transplantation Patients.

C. Fonnesbeck, A. Kassim, N. Halasa, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia.

Susan O'Brien, Jason Gotlib, Moshe Talpaz, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

Time to consider HPV vaccination after allogeneic stem cell transplantation.

A. Barrett, Stephanie J. Lee, C. Anasetti, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

New-Onset Post-Transplant Diabetes Mellitus after Allogeneic Hematopoietic Cell Transplant Is Initiated by Insulin Resistance, Not Immunosuppressive Medications.

N. Abumrad, J. Crowe, D. K. Jung, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of Psychological Distress on Quality of Life, Functional Status, and Survival in Patients with Chronic Graft-versus-Host Disease.

W. Wood, J. Pidala, Yi-Bin Chen, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Quality of Life in the Chronic GVHD Consortium Cohort: Lessons Learned and the Long Road Ahead

M. Jagasia, Christa Krupski, 2015, Current Hematologic Malignancy Reports.

Comorbidity burden in patients with chronic GVHD

W. Wood, B. Storer, J. Pidala, 2013, Bone Marrow Transplantation.

Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium.

B. Kurland, J. Pidala, Stephanie J. Lee, 2011, Blood.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

Daniel Wolff, Yoshihiro Inamoto, Sandra A Mitchell, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation

W. Wood, D. Miklos, B. Storer, 2015, Clinical Cancer Research.

Pathology of graft-versus-host disease in the gastrointestinal tract.

K. Washington, M. Jagasia, 2009, Human pathology.

Peripheral T-cell Lymphomas: Clinical Features and Prognostic Factors of 92 Cases Defined by the Revised European American Lymphoma Classification

D. Morgan, J. Greer, M. Jagasia, 2003, Leukemia & lymphoma.

Broad spectrum antibiotics and risk of graft-versus-host disease in pediatric patients transplanted for acute leukemia: association of carbapenem use with risk of acute GVHD.

M. Hall, S. Spellman, Tao Wang, 2021, Transplantation and cellular therapy.

Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia

J. Klein, M. Horowitz, J. Wingard, 2014, Clinical Cancer Research.

Measuring Therapeutic Response in Chronic Graft-versus-host-disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus- Host Disease: Iv. Response Criteria Working Group Report

Daniel Wolff, Anita Lawitschka, Sandra A. Mitchell, 2022 .

Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers

C. Vnencak-Jones, A. Kassim, J. Greer, 2012, Bone Marrow Transplantation.

Cost and quality issues in establishing hematopoietic cell transplant program in developing countries.

M. Aljurf, M. Pasquini, H. Greinix, 2017, Hematology/oncology and stem cell therapy.

Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma

J. Larkin, J. Kirkwood, H. Kluger, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Systematic screen for tyrosine kinase rearrangements identifies a novel C6orf204‐PDGFRB fusion in a patient with recurrent T‐ALL and an associated myeloproliferative neoplasm

Annette S. Kim, N. Socci, A. Viale, 2012, Genes, chromosomes & cancer.

Association of Leukocyte Adhesion and Rolling in Skin With Patient Outcomes After Hematopoietic Cell Transplantation Using Noninvasive Reflectance Confocal Videomicroscopy.

Heidi Chen, E. Tkaczyk, A. Beeghly-Fadiel, 2022, JAMA dermatology.

Chronic Myelogenous LeukemiaPractice Guidelines in Oncology TM

J. Radich, H. Borghaei, M. Tallman, 2009 .

The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.

J. Ritz, D. Miklos, M. V. D. van den Brink, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Early Th1 immunity promotes immune tolerance and may impair graft-versus-leukemia effect after allogeneic hematopoietic cell transplantation

J. Crowe, M. Rock, S. Yoder, 2016, Haematologica.

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts.

Francisco Cervantes, Ryuzo Ohno, Richard E. Clark, 2013, Blood.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.

D. Miklos, J. Pidala, E. Russek-Cohen, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Assessment of Joint and Fascia Manifestations in Chronic Graft‐Versus‐Host Disease

J. Goldberg, B. Kurland, J. Pidala, 2014, Arthritis & rheumatology.

Clofarabine plus cytarabine compared to cytarabine alone in older patients with relapsed or refractory (R/R) acute myelogenous leukemia (AML): Results from the phase III CLASSIC 1 trial.

R. Collins, P. Hari, M. Maris, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Variation in supportive care practices in hematopoietic cell transplantation.

R. Soiffer, M. Bevans, Stephanie J. Lee, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Are CAR-T therapies living up to their hype? A study using real-world data in two cohorts to determine how well they are actually working in practice compared with bone marrow transplants

A. Ludlow, M. Minnema, M. Jagasia, 2019, BMJ Evidence-Based Medicine.

Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.

W. Wood, J. Pidala, Stephanie J. Lee, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Association of Socioeconomic Status with Chronic Graft-versus-Host Disease Outcomes.

J. Pidala, L. Rybicki, Stephanie J. Lee, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Validation of International Chronic Ocular Graft-Versus-Host Disease (GVHD) Group Diagnostic Criteria as a Chronic Ocular GVHD-Specific Metric

T. Koyama, A. Kassim, B. Savani, 2017, Cornea.

Measurement of oral chronic GVHD: results from the Chronic GVHD Consortium

B. Kurland, J. Pidala, M. Flowers, 2013, Bone Marrow Transplantation.

Randomized Multicenter Trial of Sirolimus vs. Prednisone as Initial Therapy for Standard Risk Acute GVHD: BMT CTN 1501.

E. Leifer, M. Horowitz, J. Pidala, 2019, Blood.

Lymphoid and myeloid immune cell reconstitution after nicotinamide-expanded cord blood transplantation

J. Wagner, D. Cilloni, W. Tao, 2021, Bone Marrow Transplantation.

Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant.

B. Storer, J. Pidala, Stephanie J. Lee, 2016, Annals of the American Thoracic Society.

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.

J. Ritz, P. Westervelt, J. Dipersio, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk factors associated with early viral reactivation following haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: a pilot study

A. Kassim, B. Savani, M. Jagasia, 2020, Annals of Hematology.

Erdheim-chester disease mimicking multiple meningiomas syndrome.

Mahlon D. Johnson, L. Mawn, M. Jagasia, 2004, AJNR. American journal of neuroradiology.

Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP).

Heidi Chen, A. Kassim, J. Greer, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Extracorporeal photopheresis as second-line treatment for acute graft-versus-host disease: impact on six-month freedom from treatment failure

N. Russell, H. Greinix, A. Kassim, 2014, Haematologica.

Plerixafor in AL amyloidosis: improved graft composition and faster lymphocyte recovery after auto-SCT in patient with end-stage renal-disease

B. Savani, M. Jagasia, D. Dunn, 2012, Bone Marrow Transplantation.

Thus, further studies of promoter and alternative splicing SNPs and altered BAFF expression in cGVHD are warranted.

C. Béroud, D. Hamroun, M. Claustres, 2017 .

Engraftment and graft failure: Assessment and practical considerations

B. Savani, M. Jagasia, Y. Jethava, 2017 .

Endocrine complications in long-term survivors after allogeneic stem cell transplant.

M. Jagasia, S. Jagasia, U. Gunasekaran, 2012, Seminars in hematology.

When Can You Discard Stem Cells?

B. Shaw, E. Gehrie, B. Savani, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Early lymphocyte reconstitution is associated with improved transplant outcome after cord blood transplantation.

A. Kassim, H. Frangoul, J. Greer, 2011, Cytotherapy.

Optimizing Antithymocyte Globulin Dosing for Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Based on Recipient Absolute Lymphocyte Count.

Heidi Chen, A. Kassim, J. Greer, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Next-generation long-term transplant clinics: improving resource utilization and the quality of care through health information technology

J. Warner, B. Savani, M. Jagasia, 2016, Bone Marrow Transplantation.

Transfer RNA detection by small RNA deep sequencing and disease association with myelodysplastic syndromes

Annette S. Kim, K. Vickers, Yan Guo, 2015, BMC Genomics.

492 Phase 2 efficacy and safety of autologous tumor-infiltrating lymphocyte (TIL) cell therapy in combination with pembrolizumab in immune checkpoint inhibitor-naïve patients with advanced cancers

B. Monk, A. Jazaeri, A. Jimeno, 2021, Journal for ImmunoTherapy of Cancer.

Long-term follow-up of informal caregivers after allo-SCT: a systematic review

E. Wulff-Burchfield, B. Savani, M. Jagasia, 2013, Bone Marrow Transplantation.

Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802.

W. Wood, J. Pidala, E. Holler, 2018, Blood advances.

J. Warner, Heidi Chen, A. Kassim, 2021, Journal of hematology.

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy

S. Goldhaber, J. Moslehi, G. Piazza, 2019, Front. Oncol..

Chronic myelogenous leukemia.

J. Radich, D. DeAngelo, B. Smith, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study

Michael E. Egger, J. Kirkwood, P. Hari, 2022, Journal for ImmunoTherapy of Cancer.

Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease

B. Storer, J. Pidala, Stephanie J. Lee, 2014, Haematologica.

Investigator feedback about the 2005 NIH diagnostic and scoring criteria for chronic GVHD

W. Wood, J. Pidala, Stephanie J. Lee, 2014, Bone Marrow Transplantation.

Impact of prior acute GVHD on chronic GVHD outcomes: a chronic graft versus host disease consortium study

B. Kurland, J. Pidala, M. Arora, 2013, Leukemia.

Analysis of gastrointestinal and hepatic chronic graft-versus-host [corrected] disease manifestations on major outcomes: a chronic graft-versus-host [corrected] disease consortium study.

B. Kurland, J. Pidala, Stephanie J. Lee, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study

B. Storer, J. Pidala, Stephanie J. Lee, 2012, Haematologica.

Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria.

Heidi Chen, A. Kassim, H. Frangoul, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.

J. Klein, M. Horowitz, J. Wingard, 2011, Blood.

Initial Results of KD025-208: A Phase 2a Open-Label Clinical Trial of KD025 for Steroid-Dependent Chronic Graft Versus Host Disease (cGVHD)

Stephanie J. Lee, J. Ryan, O. Schueller, 2018 .

Low‐dose azacitidine after allogeneic stem cell transplantation for acute leukemia

H. Kantarjian, G. Garcia-Manero, E. Shpall, 2009, Cancer.

Biomarker Panel for Chronic Graft-Versus-Host Disease.

Philip R. Gafken, Y. Ogata, B. Storer, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term outcome after autologous or allogeneic stem cell transplantation in patients with recurrent follicular lymphoma

O. Oluwole, J. Greer, B. Savani, 2012, Bone Marrow Transplantation.

Genetic variation in recipient B-cell activating factor modulates phenotype of GVHD.

D. Crawford, K. Brown-Gentry, Heidi Chen, 2011, Blood.

Cytomegalovirus (CMV) Epitope–Specific CD4+ T Cells Are Inflated in HIV+ CMV+ Subjects

S. Mallal, P. Klenerman, S. Kalams, 2017, The Journal of Immunology.

This information is current as Subjects + CMV + T Cells Are Inflated in HIV + CD 4 Cytomegalovirus ( CMV ) Epitope-Specific

Louise, P. Klenerman, S. Kalams, 2017 .

Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignancies.

A. Kassim, S. Brandt, D. Morgan, 2012, Experimental hematology.

Clinical benefit of response in chronic graft-versus-host disease.

B. Storer, J. Pidala, Stephanie J. Lee, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hand grip strength and 2-minute walk test in chronic graft-versus-host disease assessment: analysis from the Chronic GVHD Consortium.

J. Pidala, Stephanie J. Lee, D. Weisdorf, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Randomized Controlled Study of Extracorporeal Photopheresis (ECP) Therapy with UVADEX® (Methoxsalen) for National Institutes of Health (NIH)-Graded Moderate to Severe Chronic Graft-Vs-Host Disease (cGVHD)

H. Greinix, C. Scheid, G. Socié, 2017 .

Fludarabine and Busulfan versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma.

Sonali M. Smith, P. Armand, S. Jaglowski, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study.

D. Carbone, Y. Shyr, C. Langer, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study

L. Coussens, Z. DeFilipp, Stephanie J. Lee, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Refined National Institutes of Health response algorithm for chronic graft-versus-host disease in joints and fascia.

J. Pidala, Stephanie J. Lee, M. Flowers, 2020, Blood advances.

Machine learning reveals chronic graft-versus-host disease phenotypes and stratifies survival after stem cell transplant for hematologic malignancies

J. Irish, Heidi Chen, J. Pidala, 2018, Haematologica.

Optimal Biomechanical Parameters for Measuring Sclerotic Chronic Graft-Versus-Host Disease

Heidi Chen, A. Vain, E. Tkaczyk, 2021, JID innovations.

Correction: Non-invasive measurement of sclerosis in cutaneous cGVHD patients with the handheld device Myoton: a cross-sectional study

A. Vain, E. Tkaczyk, M. Jagasia, 2019, Bone Marrow Transplantation.

Non-invasive measurement of sclerosis in cutaneous cGVHD patients with the handheld device Myoton: a cross-sectional study

A. Vain, E. Tkaczyk, M. Jagasia, 2018, Bone Marrow Transplantation.

BCR Hyper-Responsiveness In B Cells From Patients With Chronic Gvhd Is Blocked With The Syk Inhibitor R406

W. Wood, J. Serody, A. Deal, 2013 .

Validation of measurement scales in ocular graft-versus-host disease.

B. Kurland, J. Pidala, Stephanie J. Lee, 2012, Ophthalmology.

Chronic Graft versus Host Disease: Interdisciplinary Management: Diagnosis and Staging

S. Pavletic, A. Filipovich, M. Jagasia, 2009 .

Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues

M. Goswami, C. Hourigan, A. Barrett, 2014, Leukemia.

Multicenter Open-Label Phase 2 Study of Ibrutinib in Chronic Graft Versus Host Disease (cGVHD) after Failure of Corticosteroids

A. Logan, D. Miklos, M. Flowers, 2016 .

Efficacy and Pharmacoeconomic Impact of Letermovir for CMV Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients

A. Kassim, B. Savani, M. Jagasia, 2019, Biology of Blood and Marrow Transplantation.

Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling.

D. K. Jung, A. Kassim, S. Paczesny, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation

K. Ness, M. Flowers, M. Arora, 2009, Bone Marrow Transplantation.

Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort.

J. Klein, M. Horowitz, J. Wingard, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Improved survival after acute graft-versus-host disease diagnosis in the modern era

Alan M. Miller, R. Vij, W. Wood, 2017, Haematologica.

Features of cutaneous acute graft‐versus‐host disease by reflectance confocal microscopy

C. Alessi-Fox, M. Gill, S. González, 2019, The British journal of dermatology.

Minimal residual disease negativity and lenalidomide maintenance therapy are associated with superior survival outcomes in multiple myeloma

A. Kassim, C. Mosse, R. Cornell, 2020, Bone Marrow Transplantation.

Allogeneic Stem Cell Transplantation for FLT3/ITD Positive Acute Myeloid Leukemia in CR1: Implication for Personalized Therapy to Prevent Early Relapses

A. Kassim, J. Greer, M. Jagasia, 2012 .

Outcomes from Autologous Hematopoietic Cell Transplantation versus Chemotherapy Alone for the Management of Light Chain Amyloidosis.

S. Phillips, A. Kassim, A. Langone, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Amphiregulin Improves Stratification of the Refined Minnesota Acute Graft-Versus-Host Disease Risk Score: Results from BMT CTN 0302/0802

W. Wood, J. Pidala, E. Holler, 2017 .

Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease.

W. Wood, J. Pidala, Yi-Bin Chen, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Survivorship issues after transplantation

B. Savani, M. Jagasia, Vanessa E. Kennedy, 2017 .

Geographic distance is not associated with inferior outcome when using long-term transplant clinic strategy.

Heidi Chen, A. Kassim, B. Savani, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Post-allograft pomalidomide and reversible hepatotoxicity

A. Kassim, M. Jagasia, J. Pauff, 2014, Bone Marrow Transplantation.

Outcome, toxicity profile and cost analysis of autologous stem cell mobilization

A. Pickard, A. Neff, B. Savani, 2011, Bone Marrow Transplantation.

Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic Leukemia.

C. Flowers, M. Perales, A. Viswabandya, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

458 First phase 2 results of autologous tumor-infiltrating lymphocyte (TIL; LN-145) monotherapy in patients with advanced, immune checkpoint inhibitor-treated, non-small cell lung cancer (NSCLC)

S. Gettinger, L. Paz-Ares, V. Gontcharova, 2021, Journal for ImmunoTherapy of Cancer.

Phase 1 Study of Axatilimab (SNDX-6352), a CSF-1R Humanized Antibody, for Chronic Graft-Versus-Host Disease after 2 or More Lines of Systemic Treatment

Stephanie J. Lee, G. Hill, P. Ordentlich, 2020 .

Paving the Road for CAR-Ts: ASTCT 80/20 Task Force consensus on challenges and solutions to improving efficiency of clinical center certification and maintenance of operations for commercially approved immune effector cell therapies.

Matthew J. Frigault, M. Perales, B. Levine, 2023, Transplantation and cellular therapy.

Six Month Freedom from Treatment Failure is an Important Endpoint for Acute Graft-Versus-Host Disease Clinical Trials

Heidi Chen, A. Kassim, J. Greer, 2013, Bone Marrow Transplantation.

Employment, Insurance, and Financial Experiences of Patients with Chronic Graft-versus-Host Disease in North America.

G. Abel, W. Wood, J. Pidala, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Phase II Randomized Study of Lenalidomide or Lenalidomide and Rituximab As Maintenance Therapy Following R-CHOP Chemotherapy for Patients with High Risk Diffuse Large B-Cell Lymphoma

Heidi Chen, K. Richards, D. Morgan, 2012 .

Measurement of Oral Chronic Graft-Versus-Host Disease

B. Kurland, J. Pidala, M. Flowers, 2012 .

Vaccinations Efficacy in Long Term Survivors After Allogeneic Stem Cell Transplantation: Implication of Repeat Vaccinations and Documenting Vaccination Efficacy.

A. Kassim, J. Greer, B. Savani, 2009 .

Progressive multifocal leukoencephalopathy in a patient with follicular lymphoma treated with multiple courses of rituximab

T. Abel, K. Weaver, D. Morgan, 2009, Leukemia & lymphoma.

Checkpoint Blockade for Treatment of Relapsed Lymphoma Following Allogeneic Hematopoietic Cell Transplant: Use May be Complicated By Onset of Severe Acute Graft Versus Host Disease

P. Hari, P. Armand, L. Andritsos, 2016 .

The Anatomic Distribution of Skin Involvement in Patients with Incident Chronic Graft-versus-Host Disease.

Heidi Chen, J. Pidala, Stephanie J. Lee, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

434 Association of skin response in erythema and sclerosis with survival in chronic graft-versus-host disease

Heidi Chen, E. Tkaczyk, M. Jagasia, 2020 .

Overcoming human disagreement assessing erythematous lesion severity on 3D photos of chronic graft-versus-host disease

B. Dawant, E. Tkaczyk, M. Jagasia, 2018, Bone Marrow Transplantation.

Segmentation of skin lesions in chronic graft versus host disease photographs with fully convolutional networks

Benoit M. Dawant, Jianing Wang, Eric R. Tkaczyk, 2018, Medical Imaging.

Longitudinal tracking of skin dynamic stiffness to quantify evolution of sclerosis in chronic graft-versus-host disease

A. Vain, E. Tkaczyk, M. Jagasia, 2020, Bone Marrow Transplantation.

CMV exposure drives long-term CD57+ CD4 memory T cell inflation following allogeneic stem cell transplant.

Sierra M. Barone, Anupama Reddy, E. Newell, 2021, Blood.

Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemia

A. Kassim, J. Greer, B. Savani, 2018, Bone Marrow Transplantation.

Prospective Study of Apixaban for Primary Prevention of Venous Thromboembolism in Patients with Multiple Myeloma Receiving Immunomodulatory Therapy

S. Goldhaber, J. Moslehi, G. Piazza, 2018, Blood.

Prospective trial of minimal residual disease assessment by multiparametric flow cytometry for multiple myeloma in the era of bortezomib-based chemotherapy

Heidi Chen, A. Kassim, C. Mosse, 2018, Bone Marrow Transplantation.

An early-biomarker algorithm predicts lethal graft-versus-host disease and survival.

N. Kröger, F. Locatelli, E. Holler, 2018, JCI insight.

Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials.

J. Kurtzberg, O. Frankfurt, D. Cilloni, 2023, Transplantation and cellular therapy.

187TiP Phase II, multicenter study of autologous tumor infiltrating lymphocytes (TIL, LN 144/LN-145/LN-145-S1) in patients with solid tumours

A. Jimeno, S. Gettinger, H. Kluger, 2021, Journal of Thoracic Oncology.

Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis Obliterans Syndrome (BOS) after Hematopoietic Cell Transplantation

B. Storer, J. Pidala, Stephanie J. Lee, 2015 .

Abstract 2746: Preclinical activity and manufacturing feasibility of genetically modified PDCD-1 knockout (KO) tumor-infiltrating lymphocyte (TIL) cell therapy

R. Cubas, M. Jagasia, Jamie Blauvelt, 2022, Cancer Research.

A Prospective Randomized Double Blind Phase 3 Clinical Trial of Anti- T Lymphocyte Globulin (ATLG) to Assess Impact on Chronic Graft-Versus-Host Disease (cGVHD) Free Survival in Patients Undergoing HLA Matched Unrelated Myeloablative Hematopoietic Cell Transplantation (HCT)

J. Ritz, P. Westervelt, J. Dipersio, 2016 .

Interrater reproducibility of the Myoton and durometer devices to quantify sclerotic chronic graft-versus-host disease

A. Vain, E. Tkaczyk, M. Jagasia, 2023, Archives of Dermatological Research.

Ruxolitinib in Combination with Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Vs-Host Disease: Results from the Phase 2 REACH1 Trial

M. Arbushites, M. Perales, F. Dawkins, 2019, Biology of Blood and Marrow Transplantation.

883TiP A phase I/II open-label study (IOV-GM1-201) of TALEN-mediated PD-1 inactivated autologous tumor-infiltrating lymphocytes (TIL; IOV-4001) in patients with advanced melanoma and NSCLC

P. Hari, T. Wise-Draper, A. Sarnaik, 2022, Annals of Oncology.

Further examination of BAFF SNPs in cGVHD.

K. Richards, M. Jagasia, S. Sarantopoulos, 2012, Blood.

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts.

J. Radich, H. Kantarjian, D. B. Yehuda, 2013, Blood.

NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017.

J. Radich, H. Kantarjian, K. Gregory, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.

B. Storer, J. Pidala, Stephanie J. Lee, 2011, Blood.

An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease.

B. Storer, J. Pidala, Stephanie J. Lee, 2017, Blood.

Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report.

J. Pidala, M. Flowers, S. Pavletic, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort.

M. Horowitz, J. Wingard, R. Gale, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival.

J. Crowe, M. Rock, S. Yoder, 2012, Experimental hematology.

Individual physician practice variation in hematopoietic cell transplantation.

R. Soiffer, Stephanie J. Lee, S. Davies, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ibrutinib for chronic graft-versus-host disease after failure of prior therapy.

A. Logan, D. Miklos, M. Flowers, 2017, Blood.

Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis.

M. Robin, N. Russell, H. Greinix, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life.

Tueng T. Shen, J. Pidala, Stephanie J. Lee, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk-Factors for Acute Graft-Versus-Host Disease and Survival After Hematopoietic Cell Transplantation From Siblings and Unrelated Donors – An Analysis of the CIBMTR

M. Horowitz, R. Gale, Stephanie J. Lee, 2010 .

Variation in supportive care practices in hematopoietic cell transplantation.

R. Soiffer, M. Bevans, Stephanie J. Lee, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

PDGFRB-rearranged T-lymphoblastic leukemia/lymphoma occurring with myeloid neoplasms: the missing link supporting a stem cell origin

Annette S. Kim, J. Giltnane, D. Head, 2014, Haematologica.

Sexual health in hematopoietic stem cell transplant recipients

M. Mohty, B. Shaw, P. Stratton, 2015, Cancer.

Results from REACH1, a Single-Arm Phase 2 Study of Ruxolitinib in Combination with Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Vs-Host Disease

M. Arbushites, M. Perales, H. Khoury, 2018, Blood.

KD025-208: A Phase 2a Study of KD025 for Patients with Chronic Graft Versus Host Disease (cGVHD) — Pharmacodynamics and Updated Results

J. Weiss, Stephanie J. Lee, O. Schueller, 2018, Blood.

NCCN clinical practice guidelines in oncology: multiple myeloma.

J. Vose, C. Huff, A. Chanan-Khan, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease.

W. Wood, J. Pidala, Yi-Bin Chen, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A. Kassim, J. Greer, B. Savani, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802.

W. Wood, J. Pidala, J. Bolaños-Meade, 2018, Blood advances.

Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues

C. Hourigan, A. Barrett, N. Hensel, 2014, Leukemia.

Clinical Research: Supportive CareFluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation

B. Storer, J. Pidala, Stephanie J. Lee, 2016 .

Superior long-term outcome of patients with early transformation of non-Hodgkin lymphoma undergoing stem cell transplantation.

O. Oluwole, J. Greer, B. Savani, 2012, Clinical lymphoma, myeloma & leukemia.

Age and total-body irradiation in addition to corticosteroid dose are important risk factors for avascular necrosis of the bone.

M. Jagasia, S. Jagasia, A. Misfeldt, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.